Leveraging community support and platform affordances on a path to more active participation: A study of online fan fiction communities
Transformative Works and Cultures · 14.03.2024 · 42
DOI: 10.3983/twc.2024.2477 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transformative Works and Cultures, online erschienen am 14.03.2024. Verfasst von Sourojit Ghosh und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The success of online communities is driven by continuous active community participation, but motivating silent members (lurkers) to participate might push them faster than they are prepared for and demand extra labor from active members. This article explores user participation in online fan fiction communities through empirical interviews of once-silent but now-active members, demonstrating how such platforms afford lurking as a legitimate mode of participation and provide affordances for users to participate at their own pace. We propose a theory of incidental mentorship, where active users become role models within a supportive community and motivate lurkers to participate without doing additional work.
Zitieren
APA
Ghosh, S., & Aragon, C. (2024). Leveraging community support and platform affordances on a path to more active participation: A study of online fan fiction communities. Transformative Works and Cultures, 42. https://doi.org/10.3983/twc.2024.2477
Vancouver
Ghosh S, Aragon C. Leveraging community support and platform affordances on a path to more active participation: A study of online fan fiction communities. Transformative Works and Cultures. 2024;42. doi:10.3983/twc.2024.2477
BibTeX
@article{Ghosh2024,
author = {Ghosh, Sourojit and Aragon, Cecilia},
title = {Leveraging community support and platform affordances on a path to more active participation: A study of online fan fiction communities},
journal = {Transformative Works and Cultures},
year = {2024},
volume = {42},
doi = {10.3983/twc.2024.2477}
}
EUVIMED